ISCHEMIC INJURY OF KIDNEY ALLOGRAFTS AND EXPRESSION OF MATRIX METALLOPROTEINASES
https://doi.org/10.15825/1995-1191-2011-2-103-109
Abstract
In the following paper we present the literature review concerning the correlation between the ischemic injury of kidney allografts and matrix metalloproteinases activity.
About the Authors
M. L. Arefjev
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
Russian Federation
Russian Federation
M. G. Minina
Moscow coordinating centre of organ donation
Dept of Transplantology and artificials organs of Sechenov Moscow Medical Academy, Moscow
Russian Federation
Russian Federation
I. M. Iljinsky
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
Dept of Transplantology and artificials organs of Sechenov Moscow Medical Academy, Moscow
Russian Federation
Russian Federation
References
1. Биленко М.В. Ишемические и реперфузионные по- вреждения органов. М.: Медицина, 1989. 386 с.
2. Ильинский И.М., Розенталь Р.Л. Патология почеч- ных аллотрансплантатов. Рига: Зинатне, 1990. 151 с. 3. Онищенко Н.А., Шумаков В.И., Штенгольц Е.Ш.
3. Консервация органов и тканей / Под ред. акад.
4. Б.В. Петровского. М.: Медицина, 1975. 252 с.
5. Шумаков В.И., Онищенко Н.А., Кирпатовский В.И. Фармакологическая защита трансплантата. М.: Ме-
6. дицина, 1983. 149 с.
7. Ackoundou-N’Guessan C., Bismuth J., Canet S. et al.
8. Partial recovery of delayed graft function due to choles- terol emboli after renal transplantation // Saudi J. Kidney Dis. Transpl. 2008. Vol. 19. No 4. P. 631–635.
9. Bellemare S., Vigneault N., Madore F. et al. Enhanced development of caspase-independent cortical cell death during cold storage in kidneys of non-heart-beating do- nors // Transplantation. 2002. Vol. 73. No 11. P. 1742– 1751.
10. Boros P., Bromberg J.S. New cellular and molecular im- mune pathways in ischemia/reperfusion injury // Am. J. Transplant. 2006. Vol. 6. No 4. P. 652–658.
11. Butterworth P.C., Horsburgh T., Nicholson M.L. Distri- bution and predictive value of apoptosis in biopsies from non-heart-beating donor kidneys // Transplant. Proc. 2000. Vol. 32. No 1. P. 163.
12. Chapman J. Chronic allograft nephropathy. Longitudinal analysis of chronic allograft nephropathy: clinicopatho- logic correlations // Kidney Int. 2005. Vol. 68. P. S108– S112.
13. Chen W., Bennett C.F., Condon T.P. Methoxyethyl modi- fication of phosphorothioate ICAM-1 antisense oligonu- cleotides improves prevention of ischemic/reperfusion injury // Transplant. Proc. 2001. Vol. 33. No 1–2. P. 854.
14. Del Prete D., Ceol M., Anglani F. et al. Early activation of fibrogenesis in transplanted kidneys: a study on serial renal biopsies // Exp. Mol. Pathol. 2009. Vol. 87. No 2. P. 141–145.
15. Dragun D., Hoff U., Park J.K. et al. Ischemia-reperfu- sion injury in renal transplantation is independent of the immunologic background // Kidney Int. 2000. Vol. 58. No 5. P. 2166–2177.
16. Erkasap S., Ates E. L-Arginine-enriched preservation solution decreases ischaemia/reperfusion injury in cani- ne kidneys after long-term cold storage // Nephrol. Dial. Transplant. 2000. Vol. 15. No 8. P. 1224–1227.
17. Fernandez A., Royuela A., Quintas A., Zamora J. Are IL2 receptor antagonist useful in high risk acute tubular necrosis kidney recipients? // Nefrologia. 2007. Vol. 27. No 5. P. 534–536.
18. Furukawa T., Hattori R., Kinukawa T. et al. Analysis of acute rejection episodes during acute tubular necrosis // Transplant-Proc. 1994. Vol. 26. P. 1999–2000.
19. Goldberg L.C., Cook T., Taube D. Pretreatment of renal transplants with anti-CD45 antibodies: optimization of perfusion technique // Transpl. Immunol. 1994. Vol. 2. No 1. P. 27–34.
20. Goldsmith P.J., Ridgway D.M., Pine J.K. et al. Outcomes Following Renal Transplantation after Multi-Organ Retrieval versus Kidney Only Retrieval in Donation after Cardiac Death Donors // XXIII International Congress of the Transplantation Society. Vancouver, August 15–19, 2010. MO16.08.
21. Gong R., Rifai A., Tolbert E.M. et al. Hepatocyte Growth Factor Modulates Matrix Metalloproteinases and Plas- minogen Activator/Plasmin Proteolytic Pathways in Pro- gressive Renal Interstitial Fibrosis // J. Am. Soc. Neph- rol. 2003. Vol. 14. No 12. P. 3047–3060.
22. Goujon J.M., Vandewalle A., Baumert H. et al. Influence of cold-storage conditions on renal function of autotrans- planted large pig kidneys // Kidney Int. 2000. Vol. 58. No 2. P. 838–850.
23. Gwinner W., Hinzmann K., Erdbruegger U. et al. Acute tubular injury in protocol biopsies of renal grafts: preva- lence, associated factors and effect on long-term func- tion // Am. J. Transplant. 2008. Vol. 8. No 8. P. 1684– 1693.
24. Hammad F.T., Davis G., Zhang X., Wheatley A.M. The role of endothelin in early renal cortical reperfusionin re- nal transplantation // Eur. Surg. Res. 2000. Vol. 32. No 6. P. 380–388.
25. Hauet T., Baumert H., Gibelin H. et al. Citrate, acetate and renal medullary osmolyte excretion in urine as pre- dictor of renal changes after cold ischaemia and trans- plantation // Clin. Chem. Lab. Med. 2000. Vol. 38. No 11. P. 1093–1098.
26. Herrero-Fresneda I., Torras J., Lloberas N. et al. Cold ischemia in the absence of alloreactivity induces chro- nic transplant nephropathy through a process mediated by the platelet-activating factor // Transplantation. 2000. Vol. 70. No 11. P. 1624–1631.
27. Hieta N., Impola U., Lopez-Otin C. et al. Matrix metal- loproteinase-19 expression in dermal wounds and by fib- roblasts in culture // J. Invest. Dermatol. 2003. Vol. 121. P. 997–1004.
28. Impola U., Toriseva M., Suomela S. et al. Matrix Metal- loproteinase-19 is expressed by proliferating epithelium but disappears with neoplastic dedifferentiation // Int. J. Cancer. 2003. Vol. 103. P. 709–716.
29. Israni A.K., Li N., Cizman B.B. et al. Association of donor inflammation- and apoptosis-related genoty- pes and delayed allograft function after kidney trans- plantation // Am. J. Kidney Dis. 2008. Vol. 52. No 2. P. 331–339.
30. Jain S., Bicknell G.R., Whiting P.H., Nicholson M.L. Ra- pamycin reduces expression of fibrosis-associated genes in an experimental model of renal ischaemia reperfu- sion injury // Transplant. Proc. 2001. Vol. 33. No 1–2. P. 556–558.
31. Kaden J. J., Dempfle C.E., Grobholz R. et al. Interleu- kin-1 beta promotes matrix metalloproteinase expressi- on and cell proliferation in calcific aortic valve steno- sis // Curr. Top. Microbiol. Immunol. 2004. Vol. 280. P. 165–189.
32. Kaneku H.K., Terasaki P.I. Thirty year trend in kidney transplants: UCLA and UNOS Renal Transplant Regist- ry // Clin. Transpl. 2006. No 1. P. 27.
33. Kato R., Momiyama Y., Ohmori R. et al. Levels of mat- rix metalloproteinase-1 in patients with and without co-
34. ronary artery disease and relation to complex and non- complex coronary plaques // Am. J. of Cardiology. 2005. Vol. 95. No 1. P. 90–92.
35. Khanna A.K., Hosenpud J.S., Plummer M.S., Hosen- pud J.D. Analysis of transforming growth factor-beta and profibrogenic molecules in a rat cardiac allograft model treated with cyclosporine // Transplantation. 2002. Vol. 73. No 10. P. 1543–1549.
36. Kouwenhoven E.A., de Bruin R.W., Bajema I.M. et al. Cold ischemia augments allogeneic-mediated injury in rat kidney allografts // Kidney Int. 2001. Vol. 59. No 3. P. 1142–1148.
37. Kusaka M., Kuroyanagi Y., Ichino M. et al. The incre- ment of serum tissue inhibitor of metalloproteinases 1 (TIMP-1) predicts organ recovery from delayed graft function after kidney transplantation from donors af- ter cardiac death // XXIII International Congress of the Transplantation Society. Vancouver, August 15–19, 2010. P. 39.16.
38. Lauzurica R., Pastor M.C., Bayes B. et al. Pretransplant inflammation: a risk factor for delayed graft function? // J. Nephrol. 2008. Vol. 21. No 2. P. 221–228.
39. Lehtonen S.R., Taskinen E.I., Isoniemi H.M. Histopatho- logical findings in renal allografts at time of transplanta- tion and correlation with onset of graft function // Acta Pathol. Microbiol. Immunol. (Scand). 1999. Vol. 107. P. 945–950.
40. Li M., Nicholls K.M., Becker G.J. Risk factors for late re- nal allograft dysfunction: effects of baseline glomerular size // J. Nephrol. 2002. Vol. 15. No 6. P. 620–625.
41. Lutz J., Luong L.A., Strobl M. et al. The A20 gene pro- tects kidneys from ischaemia/reperfusion injury by sup- pressing pro-inflammatory activation // J. Mol. Med. 2008.
42. Marti H.P. The role of matrix metalloproteinases in the activation of mesangial cells // Transpl. Immunol. 2002. Vol. 9. No 2–4. P. 97–100.
43. Mengel M., Bock O., Priess M. et al. Expression of pro- and antifibrotic genes in protocol biopsies from renal allografts with interstitial fibrosis and tubular atrophy // Clin. Nephrol. 2008. Vol. 69. No 6. P. 408–416.
44. Mikhalski D., Wissing K.M., Ghisdal L. et al. Cold ische- mia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression // Transplantation. 2008. Vol. 85. No 7. P. S3–9.
45. Moller H.E., Gaupp A., Dietl K. et al. Tissue pH in hu- man kidney transplants during hypothermic ischemia // Magn. Reson. Imaging. 2000. Vol. 18. No 6. P. 743–751.
46. Nagase H., Visse R., Murphy G. Structure and function of matrix metalloproteinases and TIMPs // Cardiovas- cular Research (Oxford Journals). 2005. Vol. 69. No 3. P. 562–573.
47. Nicholson M.L., Waller J.R., Bicknell G.R. Renal trans- plant fibrosis correlates with intragraft expression of tis- sue inhibitor of metalloproteinase messenger RNA // Br. J. Surg. 2002. Vol. 89. No 7. P. 933–937.
48. Novak K.B., Le H.D., Christison-Lagay E.R. et al. Ef- fects of metalloproteinase inhibition in a murine mo- del of renal ischemia-reperfusion injury // Pediatr. Res. 2010. Vol. 67. No 3. P. 257–262.
49. Oberbauer R., Rohrmoser M., Regele H. et al. Apoptosis of tubular epithelial cells in donor kidney biopsies pre- dicts early renal allograft function // J. Am. Soc. Neph- rol. 1999. Vol. 10. P. 2006–2013.
50. Oda A., Morozumi K., Uchida K. Histological factors of 1-h biopsy influencing the delayed renal function and outcome in cadaveric renal allografts // Clin. Transplant. 1999. Vol. 13. Suppl. 1. P. 6–12.
51. Pallet N., Thervet E., Legendre C., Anglicheau D. Siroli- mus early graft nephrotoxicity: clinical and experimental data // Curr. Drug Saf. 2006. Vol. 1. No 2. P. 179–187.
52. Palomar R., Mayorga M., Ruiz J.C. et al. Markers of fi- brosis in early biopsies of renal transplants // Transplant. Proc. 2005. Vol. 37. No 3. P. 1468–1470.
53. Salahudeen A.K., Huang H., Joshi M. et al. Involve- ment of the mitochondrial pathway in cold storage and rewarming-associated apoptosis of human renal proxi- mal tubular cells // Am. J. Transplant. 2003. Vol. 3. No 3. P. 273–280.
54. Salahudeen A.K., Joshi M., Jenkins J.K. Apoptosis versus necrosis during cold storage and rewarming of human renal proximal tubular cells // Transplantation. 2001. Vol. 72. No 5. P. 798–804.
55. Salahudeen A.K., May W. Reduction in cold ischemia time of renal allografts in the United States over the last decade // Transplant. Proc. 2008. Vol. 40. No 5. P. 1285– 1289.
56. Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases // J. Pathol. 2003. Vol. 200. No 4. P. 448–464.
57. Tayebjee M.H., Lip G.Y.H., Blann A.D., MacFadyen R.J. Effects of age, gender, ethnicity, diurnal variation and
58. exercise on circulating levels of matrix metalloprotei- nases (MMP)-2 and -9, and their inhibitors, tissue inhi- bitors of matrix metalloproteinases (TIMP)-1 and -2 // Thrombosis Research. 2005. Vol. 115. No 3. P. 205–210.
59. Tullius S.G., Nieminen-Kelha M., Bachmann U. et al. Induction of heme-oxygenase-1 prevents ischemia/re- perfusion injury and improves long-term graft outcome in rat renal allografts//Transplant. Proc. 2001. Vol. 33. No 1–2. P. 1286–1287.
60. Van den Eijnden M.M., Leuvenink H.G., Ottens P.J. et al. Effect of brain death and non-heart-beating kidney do- nation on renal function and injury: an assessment in the isolated perfused rat kidney // Exp. Clin. Transplant. 2003. Vol. 1. No 2. P. 85–95.
61. Vu T.H., Werb Z. Matrix metalloproteinases: effectors of development and normal physiology // Genes Dev. 2000. Vol. 14. No 17. P. 2123–2133.
62. Yang C.W., Ahn H.J., Han H.J. et al. Pharmacological preconditioning with low-dose cyclosporine or FK506 reduces subsequent ischemia/reperfusion injury in rat kidney // Transplantation. 2001. Vol. 72. No 11. P. 1753– 1759.
63. Zhou M., Zhang Y., Ardans J.A., Wahl L.M. Interferon- gamma differentially regulates monocyte matrix me- talloproteinase-1 and -9 through tumor necrosis factor- alpha and caspase 8 // J. Biol. Chem. 2003. Vol. 278. P. 45406–45413.
64. Ziswiler R., Daniel C., Franz E., Marti H.P. Renal matrix metalloproteinase activity is unaffected by experimental ischemia-reperfusion injury and matrix metalloproteina- se inhibition does not alter outcome of renal function // Exp. Nephrol. 2001. Vol. 9. No 2. P. 118–124.
Review
For citations:
Arefjev M.L., Minina M.G., Iljinsky I.M. ISCHEMIC INJURY OF KIDNEY ALLOGRAFTS AND EXPRESSION OF MATRIX METALLOPROTEINASES. Russian Journal of Transplantology and Artificial Organs. 2011;13(2):103-109. (In Russ.) https://doi.org/10.15825/1995-1191-2011-2-103-109
Views:
751
Email this article 